Drugs / Hexetidine
Hexetidine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT01115049 | Feb → Mar 2010 | mucositis | Federico II University | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07868549 | Jun → Sep 2026 overdue | — | University of Zagreb | Enrolling by invitation | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hexetidine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01115049 ↗ |
| Known as | Hexetidina | ChEMBL registry synonym — accepted as the source's own label CHEMBL144673 ↗ |
| Known as | NSC-17764 | ChEMBL registry synonym — accepted as the source's own label CHEMBL144673 ↗ |
| Known as | Oraldene | ChEMBL registry synonym — accepted as the source's own label CHEMBL144673 ↗ |
| Known as | Sterisil | ChEMBL registry synonym — accepted as the source's own label CHEMBL144673 ↗ |
| Modality | Small molecule | — CHEMBL144673 ↗ |
| Route | Topical | “Application of hexetidine to the oral cavity using sterile gauze and a spatula after mechanical cleaning, twice daily.” NCT07868549 ↗ |